Bio-Rad Laboratories
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Bio-Rad Laboratories's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 5% to $2,671,262,000. The net income raised on -$637,324,000 and profit margin reached -24%. Total operating expenses were $1,089,150,000.
Profit Margin
| 2014 | 2.17B | 88.84M | 4.08% |
|---|---|---|---|
| 2015 | 2.01B | 113.09M | 5.6% |
| 2016 | 2.06B | 28.12M | 1.36% |
| 2017 | 2.16B | 114.74M | 5.31% |
| 2018 | 2.29B | 360.99M | 15.76% |
| 2019 | 2.31B | 1.75B | 76.08% |
| 2020 | 2.54B | 3.81B | 149.83% |
| 2021 | 2.92B | 4.25B | 145.57% |
| 2022 | 2.80B | -3.62B | -129.45% |
| 2023 | 2.67B | -637.32M | -23.86% |
BIO Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 2.67B | 2.80B | 2.92B | 2.54B | 2.31B | 2.29B | 2.16B | 2.06B | 2.01B | 2.17B |
Cost of revenue | 1.23B | 1.23B | 1.28B | 1.10B | 1.05B | 1.06B | 972.75M | 930.08M | 897.77M | 996.52M |
Gross profit | 1.43B | 1.56B | 1.64B | 1.43B | 1.25B | 1.22B | 1.18B | 1.13B | 1.12B | 1.17B |
Operating exp. | ||||||||||
Research and development | 226.92M | 256.88M | 271.65M | 226.59M | 202.71M | 199.19M | 250.30M | 205.86M | 192.97M | 220.33M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | -1.48M | 0 | 0 | 0 | 0 |
Total operating expenses | 1.08B | 1.08B | 1.15B | 1.02B | 1.02B | 1.03B | 1.05B | 1.02B | 954.96M | 1.02B |
Operating income | 365.69M | 482.61M | 489.43M | 410.95M | 229.66M | -108.64M | 116.65M | 53.19M | 166.70M | 149.98M |
Other income (expenses), net | -1.21B | -5.18B | 4.94B | 4.48B | 2.03B | 339.44M | -15.35M | -51.99M | -20.86M | -18.42M |
Income before tax | -850.10M | -4.70B | 5.43B | 4.90B | 2.26B | 507.35M | 97.80M | 41.56M | 145.84M | 131.55M |
Income tax expense | -212.78M | -1.07B | 1.19B | 1.10B | 502.40M | 146.36M | -16.93M | 13.43M | 32.75M | 42.71M |
Net income | -637.32M | -3.62B | 4.25B | 3.81B | 1.75B | 360.99M | 114.74M | 28.12M | 113.09M | 88.84M |
Earnings per share | ||||||||||
Basic EPS | -21.82 | -121.79 | 142.61 | 127.86 | 58.93 | 12.1 | 4.12 | 0.88 | 3.74 | 3.08 |
Diluted EPS | -21.82 | -121.79 | 140.83 | 126.2 | 58.27 | 11.94 | 4.07 | 0.88 | 3.71 | 3.05 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |